Literature DB >> 27544515

The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis.

Roman Shrestha1,2, Damian Weikum3, Michael Copenhaver4,5, Frederick L Altice4,3,6,7.   

Abstract

Prior research has widely recognized neurocognitive impairment (NCI), depression, and alcohol use disorders (AUDs) as important negative predictors of health-related quality of life (HRQoL) among people living with HIV (PLWH). No studies to date, however, have explored how these neuropsychological factors operate together and affect HRQoL. Incarcerated male PLWH (N = 301) meeting criteria for opioid dependence were recruited from Malaysia's largest prison. Standardized scales for NCI, depression, alcohol use disorders (AUDs) and HRQoL were used to conduct a moderated mediation model to explore the extent to which depression mediated the relationship between NCI, HRQoL, and AUDs using an ordinary least squares regression-based path analytic framework. Results showed that increasing levels of NCI (B = -0.1773, p < 0.001) and depression (B = -0.6147, p < 0.001) were negatively associated with HRQoL. The effect of NCI on HRQoL was significantly (Sobel z = -3.5600, p < 0.001) mediated via depression (B = -0.1230, p < 0.001). Furthermore, the conditional indirect effect of NCI on HRQoL via depression for individuals with AUDs was significant (B = -0.9099, p = 0.0087), suggesting a moderated mediation effect. The findings disentangle the complex relationship using a moderated mediation model, demonstrating that increasing levels of NCI, which can be reduced with HIV treatment, negatively influenced HRQoL via depression for individuals with AUDs. This highlights the need for future interventions to target these complex interplay between neuropsychological factors in order to improve HRQoL among PLWH, particularly incarcerated PLWH with AUDs.

Entities:  

Keywords:  Alcohol use disorders; Depression; HIV/AIDS; Health-related quality of life; Neurocognitive impairment; Opioid dependence; Prisoners

Mesh:

Year:  2017        PMID: 27544515      PMCID: PMC5318281          DOI: 10.1007/s10461-016-1526-3

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  74 in total

1.  A SWOT Analysis of the Updated National HIV/AIDS Strategy for the U.S., 2015-2020.

Authors:  David R Holtgrave; Robert Greenwald
Journal:  AIDS Behav       Date:  2016-01

2.  Addressing Moderated Mediation Hypotheses: Theory, Methods, and Prescriptions.

Authors:  Kristopher J Preacher; Derek D Rucker; Andrew F Hayes
Journal:  Multivariate Behav Res       Date:  2007 Jan-Mar       Impact factor: 5.923

3.  Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.

Authors:  Jaimie P Meyer; Javier Cepeda; Johnny Wu; Robert L Trestman; Frederick L Altice; Sandra A Springer
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

4.  Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment.

Authors:  Roman Shrestha; Pramila Karki; Tania B Huedo-Medina; Michael Copenhaver
Journal:  J Assoc Nurses AIDS Care       Date:  2016-09-22       Impact factor: 1.354

5.  HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study.

Authors:  Jaimie P Meyer; Javier Cepeda; Sandra A Springer; Johnny Wu; Robert L Trestman; Frederick L Altice
Journal:  Lancet HIV       Date:  2014-11-01       Impact factor: 12.767

6.  Relationship between depression and quality of life in persons with HIV infection in Nigeria.

Authors:  Abiodun O Adewuya; Mohammed O Afolabi; Bola A Ola; Olorunfemi A Ogundele; Adeola O Ajibare; Bamidele F Oladipo; Ibiyemi Fakande
Journal:  Int J Psychiatry Med       Date:  2008       Impact factor: 1.210

7.  Quality of life and physical functioning in HIV-infected individuals receiving antiretroviral therapy in KwaZulu-Natal, South Africa.

Authors:  Patricia A McInerney; Busisiwe P Ncama; Dean Wantland; Busisiwe R Bhengu; Chris McGibbon; Sheila M Davis; Inge B Corless; Patrice K Nicholas
Journal:  Nurs Health Sci       Date:  2008-12       Impact factor: 1.857

8.  Accessing antiretroviral therapy following release from prison.

Authors:  Jacques Baillargeon; Thomas P Giordano; Josiah D Rich; Z Helen Wu; Katherine Wells; Brad H Pollock; David P Paar
Journal:  JAMA       Date:  2009-02-25       Impact factor: 56.272

9.  Associations between alcohol use disorders and adherence to antiretroviral treatment and quality of life amongst people living with HIV/AIDS.

Authors:  Bach Xuan Tran; Long Thanh Nguyen; Cuong Duy Do; Quyen Le Nguyen; Rachel Marie Maher
Journal:  BMC Public Health       Date:  2014-01-10       Impact factor: 3.295

10.  Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community.

Authors:  Lyuba Azbel; Jeffrey A Wickersham; Yevgeny Grishaev; Sergey Dvoryak; Frederick L Altice
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more
  12 in total

1.  A Moderated Mediation Model of HIV-Related Stigma, Depression, and Social Support on Health-Related Quality of Life among Incarcerated Malaysian Men with HIV and Opioid Dependence.

Authors:  Roman Shrestha; Michael Copenhaver; Alexander R Bazazi; Tania B Huedo-Medina; Archana Krishnan; Frederick L Altice
Journal:  AIDS Behav       Date:  2017-04

2.  A Self-Report Measure to Detect Neurocognitive Impairment among Incarcerated People Living with HIV in Malaysian Context: An Exploratory Factor Analysis.

Authors:  Roman Shrestha; Damian Weikum; Michael Copenhaver; Frederick L Altice
Journal:  Int J Ment Health Addict       Date:  2017-04-03       Impact factor: 3.836

3.  Intent to Use Preexposure Prophylaxis (PrEP), HIV Risk Behaviors, and Self-Report Neurocognitive Symptoms by High-Risk Drug Users: A Mediation Analysis.

Authors:  Roman Shrestha; Pramila Karki; Tania B Huedo-Medina; Michael Copenhaver
Journal:  J Assoc Nurses AIDS Care       Date:  2017-04-19       Impact factor: 1.354

4.  Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment.

Authors:  Roman Shrestha; Pramila Karki; Tania B Huedo-Medina; Michael Copenhaver
Journal:  J Assoc Nurses AIDS Care       Date:  2016-09-22       Impact factor: 1.354

5.  Frailty and Neurocognitive Impairment: Impacts on Quality of Life in HIV.

Authors:  Anna A Rubtsova; Samir Sabbag; Erin Sundermann; Annie L Nguyen; Ronald J Ellis; David J Moore; Scott Letendre; Dilip V Jeste; María J Marquine
Journal:  J Assoc Nurses AIDS Care       Date:  2020 May-Jun       Impact factor: 1.354

6.  Developing an Integrated, Brief Biobehavioral HIV Prevention Intervention for High-Risk Drug Users in Treatment: The Process and Outcome of Formative Research.

Authors:  Roman Shrestha; Frederick Altice; Pramila Karki; Michael Copenhaver
Journal:  Front Immunol       Date:  2017-05-11       Impact factor: 7.561

7.  Neurocognitive impairment and health-related quality of life among people living with Human Immunodeficiency Virus (HIV).

Authors:  Philip S Amara; Zaeema Naveed; Christopher S Wichman; Howard S Fox; Lorena Baccaglini
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

8.  Preference for and Efficacy of a PrEP Decision Aid for Women with Substance Use Disorders.

Authors:  Jaimie Meyer; Carolina Price; DeShana Tracey; Laurel Sharpless; Yue Song; Lynn Madden; Glyn Elwyn; Frederick Altice
Journal:  Patient Prefer Adherence       Date:  2021-09-01       Impact factor: 2.711

9.  Effects of aerobic exercise on quality of life of people with HIV-associated neurocognitive disorder on antiretroviral therapy: a randomised controlled trial.

Authors:  Martins Nweke; Nombeko Mshunqane; Nalini Govender; Aderonke O Akinpelu; Adesola Ogunniyi
Journal:  BMC Infect Dis       Date:  2022-04-29       Impact factor: 3.667

10.  Impact of HIV-associated cognitive impairment on functional independence, frailty and quality of life in the modern era: a meta-analysis.

Authors:  Martins Nweke; Nombeko Mshunqane; Nalini Govender; Aderonke O Akinpelu; Maryjane Ukwuoma
Journal:  Sci Rep       Date:  2022-04-19       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.